Design of a Phase 3, Randomized, Placebo-controlled Trial of TofersenInitiated in Clinically Presymptomatic SOD1 Mutation Carriers with aLongitudinal Natural History Run-in

Journal article

Peer reviewed

NEUROLOGY, Vol.96(15, S)

2021

Metrics

1 Record Views

Title: Design of a Phase 3, Randomized, Placebo-controlled Trial of TofersenInitiated in Clinically Presymptomatic SOD1 Mutation Carriers with aLongitudinal Natural History Run-in
Creators: Michael Benatar - UMMG Department of Neurology
Publication Details: NEUROLOGY, Vol.96(15, S)
Publisher: LIPPINCOTT WILLIAMS & WILKINS; TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
Academic Unit: Miller School of Medicine; UMMG Department of Neurology; UMMG Dept of Neurology - Neuromuscular Disorders Div
Language: English
Resource Type: Journal article
Record Identifier: 991032830845302976